Keros Therapeutics, Inc.Keros Therapeutics, Inc.Keros Therapeutics, Inc.

Keros Therapeutics, Inc.

No trades
See on Supercharts

KROS fundamentals

The current financial position of Keros Therapeutics, Inc.

Total assets of KROS for Q3 24 is 579.27 M USD, 27.31% more than the previous Q2 24. And total liabilities increased by 36.15% in Q3 24 to 46.44 M USD.

Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Total assets
Total liabilities
Currency: USD
Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Total assetsYoY growth
Total equityYoY growth